Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company PTC Therapeutics Inc.
DescriptionBMI1 polycomb ring finger oncogene (BMI1) inhibitor
Molecular Target BMI1 polycomb ring finger oncogene (BMI1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today